Identifying markers of atrial cardiopathy to predict ischemic stroke
Markers of Atrial Cardiopathay
Assiut University · NCT05623969
This study is testing if signs of heart problems in people with palpitations can help predict their risk of having a stroke over the next year.
Quick facts
| Study type | Observational |
|---|---|
| Enrollment | 30 (estimated) |
| Ages | 17 Years to 90 Years |
| Sex | All |
| Sponsor | Assiut University (other) |
| Locations | 1 site (Assiut) |
| Trial ID | NCT05623969 on ClinicalTrials.gov |
What this trial studies
This observational study aims to detect the presence and degree of atrial dysfunction or atrial cardiopathy in patients experiencing palpitations. Participants will undergo Holter monitoring, echocardiography, and speckle tracking echocardiography to assess their condition. The study will follow these patients for one year to monitor any cardioembolic events, such as strokes or transient ischemic attacks (TIAs). The goal is to establish a predictive value for atrial cardiopathy in relation to ischemic stroke risk.
Who should consider this trial
Good fit: Ideal candidates are patients experiencing palpitations who are referred for Holter monitoring.
Not a fit: Patients with valvular atrial fibrillation, significant valvular heart disease, recent myocardial infarction, or specific cardiomyopathies may not benefit from this study.
Why it matters
Potential benefit: If successful, this study could help identify patients at higher risk for ischemic stroke, allowing for earlier intervention and improved patient outcomes.
How similar studies have performed: While this approach is focused on atrial cardiopathy, similar studies have shown promise in identifying stroke risk factors, suggesting potential for success.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Patients complaining of palpitation referred for Holter monitoring Exclusion Criteria: * • Valvular AF, moderate to severe mitral/ tricuspid/ aortic stenosis or regurgitation. * Recent myocardial infarction within 3 months. * Acute pulmonary embolism. * Newly onset AF during or shortly after cardiac surgery. * Specific type of cardiomyopathy such as cardiac amyloidosis, obstructive hypertrophic cardiomyopathy. Decompensation stage of organ failure
Where this trial is running
Assiut
- Mariam zarief farhan — Assiut, Egypt (RECRUITING)
Study contacts
- Principal investigator: Mohammed Aboelkassem Farghal, professor — Assiut University
- Study coordinator: Mariam zarief farhan, resident
- Email: mariamzarif134@gmail.com
- Phone: 01009427245
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.
Conditions: Atrial Cardiopathy